title: [Patient information before bladder wall injection of botulinum toxin A (Botox®): Which essential items? Results of Delphi consensus from GENULF experts].
abstract: BACKGROUND
  Preoperative information before bladder wall injection of botulinum toxin A (Botox®) holds several essential facts to understand and retain by the patients. The aim of this study was a review of essential preoperative information items according to GENULF medical experts.
  
  
  METHODS
  It was a prospective review from December 2015 to April 2016. Three Delphi rounds had been done from the Survey Monkey®software. The initial questionnaire was composed of items from the patient information sheet edited by the GENULF. Each item had been rated by the medical expert on a numeric scale of importance for patient information. The last round asked to experts to confirm items eventually selected.
  
  
  RESULTS
  A list of 27 items regarded as essentials for patient information had been checked by experts after three Delphi rounds, confirmed by 15/19 experts (75%). Best rated items were "learning self-catheterisation is essential" (mean interest 8,5/9 ; number of rate 8 or 9: 15), "kidney are protected over the long term" (mean interest 8,3/9 ; number of rate 8 or 9: 15), "efficiency is 6 to 9 months long" (mean interest 8,2/9 ; number of rate 8 or 9: 14). Discrepancies were mostly on lack of distinction between neurologic and non-neurologic patients.
  
  
  CONCLUSIONS
  We identified accurate items considered as essential for preoperative information to patients before bladder wall injection of botulinum toxin A (Botox®) by a Delphi method recommended by HAS.
  
  
  METHODS
  4.
authors.affiliation: CHU Lyon Sud, 69310 Pierre-Bénite, France. Electronic address: inesdominique40@gmail.com.
authors.forename: I
authors.initials: I
authors.lastname: Dominique
authors.affiliation: Centre hygée - centre régional de prévention des cancers, Institut de cancérologie Lucien-Neuwirth, 42270 Saint-Priest-en-Jarez, France. Electronic address: Aurelie.BOURMAUD@icloire.fr.
authors.forename: A
authors.initials: A
authors.lastname: Bourmaud
authors.affiliation: CHU Lyon Sud, 69310 Pierre-Bénite, France. Electronic address: blandine.tamarelle@chu-lyon.fr.
authors.forename: B
authors.initials: B
authors.lastname: Tamarelle
authors.affiliation: CHU Lyon Sud, 69310 Pierre-Bénite, France. Electronic address: jean-etienne.terrier01@chu-lyon.fr.
authors.forename: J E
authors.initials: JE
authors.lastname: Terrier
authors.affiliation: CHU Lyon Sud, 69310 Pierre-Bénite, France. Electronic address: alain.ruffion@chu-lyon.fr.
authors.forename: A
authors.initials: A
authors.lastname: Ruffion
mesh_terms: D000283:Administration, Intravesical; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D003697:Delphi Technique; D006801:Humans; D010353:Patient Education as Topic; D011446:Prospective Studies
chemical_list: D019274:Botulinum Toxins, Type A
keywords: Delphi; GENULF; Hyperactivité vésicale; Information patient; Onabotulinum toxin A; Onabutilium toxine A; Overactive bladder; Patient information